Literature DB >> 10683617

GB virus C in patients with liver disease of unknown etiology.

E Quirós1, G Piédrola, C Maroto.   

Abstract

To assess the prevalence of GBV-C in patients suffering unknown liver disease we have investigated the GBV-C-RNA in serum of 54 patients: 10 with acute and 32 with chronic non-A-E hepatitis (16 active and 16 persistent), 10 with hepatocellular carcinoma, 2 diagnosed with hepatic fulminant failure, and 91 healthy blood donors (control). PCR with primers from NS3 helicase region was performed and the product was identified by a double strand DNA enzyme immunoassay. GBV appears to infect 40 and 31% of acute or chronic non-A-E hepatitis respectively. Also the GBV genome was found in 1 in 10 samples of hepatocarcinoma, in 2 cases of fulminant hepatitis, and in 1 in 91 of the control group. In spite of these results the role of GBV in the etiology of liver diseases has to be analyzed in more comprehensive studies. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10683617      PMCID: PMC6807736     

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  16 in total

Review 1.  New hepatitis viruses.

Authors:  S Heringlake; H L Tillmann; M P Manns
Journal:  J Hepatol       Date:  1996-08       Impact factor: 25.083

2.  Vertical transmission of hepatitis G.

Authors:  H H Feucht; B Zollner; S Polywka; R Laufs
Journal:  Lancet       Date:  1996-03-02       Impact factor: 79.321

3.  Hepatitis G infection in drug abusers with chronic hepatitis C.

Authors:  T Aikawa; Y Sugai; H Okamoto
Journal:  N Engl J Med       Date:  1996-01-18       Impact factor: 91.245

4.  DNA enzyme immunoassay: general method for detecting products of polymerase chain reaction.

Authors:  G Mantero; A Zonaro; A Albertini; P Bertolo; D Primi
Journal:  Clin Chem       Date:  1991-03       Impact factor: 8.327

5.  Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology.

Authors:  M Yoshiba; H Okamoto; S Mishiro
Journal:  Lancet       Date:  1995-10-28       Impact factor: 79.321

6.  Infection with GB virus C (GBV-C) in patients with chronic liver disease or on maintenance hemodialysis in Indonesia.

Authors:  F Tsuda; S Hadiwandowo; N Sawada; M Fukuda; T Tanaka; H Okamoto; Y Miyakawa; M Mayumi
Journal:  J Med Virol       Date:  1996-07       Impact factor: 2.327

7.  Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis.

Authors:  T P Leary; A S Muerhoff; J N Simons; T J Pilot-Matias; J C Erker; M L Chalmers; G G Schlauder; G J Dawson; S M Desai; I K Mushahwar
Journal:  J Med Virol       Date:  1996-01       Impact factor: 2.327

8.  Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions.

Authors:  F Deinhardt; A W Holmes; R B Capps; H Popper
Journal:  J Exp Med       Date:  1967-04-01       Impact factor: 14.307

9.  Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent.

Authors:  J Linnen; J Wages; Z Y Zhang-Keck; K E Fry; K Z Krawczynski; H Alter; E Koonin; M Gallagher; M Alter; S Hadziyannis; P Karayiannis; K Fung; Y Nakatsuji; J W Shih; L Young; M Piatak; C Hoover; J Fernandez; S Chen; J C Zou; T Morris; K C Hyams; S Ismay; J D Lifson; G Hess; S K Foung; H Thomas; D Bradley; H Margolis; J P Kim
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

10.  Infection with hepatitis GB virus C in patients on maintenance hemodialysis.

Authors:  K Masuko; T Mitsui; K Iwano; C Yamazaki; K Okuda; T Meguro; N Murayama; T Inoue; F Tsuda; H Okamoto; Y Miyakawa; M Mayumi
Journal:  N Engl J Med       Date:  1996-06-06       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.